play_arrow

keyboard_arrow_right

Listeners:

Top listeners:

skip_previous skip_next
00:00 00:00
chevron_left
Go to album
  • cover play_arrow

    Energy 90.5 Top Music Radio

News

FDA clears first CRISPR treatment for a second disease, beta thalassemia

todayJanuary 16, 2024 5

Background
share close
FDA clears first CRISPR treatment for a second disease, beta thalassemia
The US Food and Drug Administration has approved a second use for the first CRISPR-based medicine, Casgevy, which was approved in December to treat sickle cell disease.

​ The US Food and Drug Administration has approved a second use for the first CRISPR-based medicine, Casgevy, which was approved in December to treat sickle cell disease. Read More Breaking News, Latest News and Videos | CNN 

Written by:

Rate it
0%